Walvax Biotechnology Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs. | ||||
Founding Date | Founding Date 2001 | Founding Date 1890 | Founding Date 1965 | Founding Date 1916 |
Type | Type Public | Type Private | Type Private | Type Public |
Tags | ||||
Locations | Locations Kunming, CN HQ | Locations ID HQ | Locations Karachi, PK HQ Karachi, PK Karachi, PK Lahore, PK | Locations Parkville, AU HQ King Of Prussia, US |
Employees | Employees 2,388 | Employees 1,1802% increase | Employees 2,2631% increase | Employees 32,698 |
Valuation ($) | Valuation ($) 3.3 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 95.1 b |
Financial | ||||
Revenue (est.) | Revenue (est.) ¥4.1b (FY, 2023) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $14.7b (FY, 2024) |
Cost of goods | Cost of goods ¥597.6m (FY, 2023) | Cost of goods N/A | Cost of goods N/A | Cost of goods $6.2b (FY, 2024) |
Gross profit | Gross profit ¥3.5b (FY, 2023) | Gross profit N/A | Gross profit N/A | Gross profit $8.6b (FY, 2024) |
Net income | Net income ¥511.3m (FY, 2023) | Net income N/A | Net income N/A | Net income $2.7b (FY, 2024) |